ASC4OPT Trial in Progress: a Phase 3B Open-label Study to optimize Oral Asciminib Therapy for chronic Myeloid Leukemia in chronic Phase after Pretreatment with 2 TKIs
ONCOLOGY RESEARCH AND TREATMENT(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要